Healthia Ltd
ASX:HLA

Watchlist Manager
Healthia Ltd Logo
Healthia Ltd
ASX:HLA
Watchlist
Price: 1.795 AUD
Market Cap: 252.1m AUD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

There is not enough data to reliably calculate the relative value of HLA.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HLA Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

1
P/S
P/S
Price to Sales
1
vs History
vs Industry
Median 3Y
1
Median 5Y
1
Industry
2.2
Forward
0.9
More Details
46
P/E
P/E
Price to Earnings
46
vs History
vs Industry
Median 3Y
46
Median 5Y
46
Industry
21.8
Forward
16.1
More Details
11.1
P/OCF
P/OCF
Price to OCF
11.1
vs History
vs Industry
Median 3Y
11.1
Median 5Y
10.9
Industry
13.6
More Details
11.3
P/FCFE
P/FCFE
Price to FCFE
11.3
vs History
vs Industry
Median 3Y
11.3
Median 5Y
8.7
Industry
19.9
More Details
1.6
P/B
P/B
Price to Book Value
1.6
vs History
vs Industry
Median 3Y
1.6
Median 5Y
1.6
Industry
2.1
More Details
1.6
EV/S
EV/S
Enterprise Value to Sales
1.6
vs History
vs Industry
Median 3Y
1.6
Median 5Y
1.6
Industry
2.3
Forward
1.4
More Details
1.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.7
vs History
vs Industry
Median 3Y
1.7
Median 5Y
1.7
Industry
4.9
More Details
13.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13.2
vs History
vs Industry
Median 3Y
13.2
Median 5Y
16.2
Industry
11.5
Forward
9.1
More Details
13.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
13.2
vs History
vs Industry
Median 3Y
13.2
Median 5Y
16.2
Industry
15.7
Forward
10.2
More Details
17.4
EV/OCF
EV/OCF
Enterprise Value to OCF
17.4
vs History
vs Industry
Median 3Y
17.4
Median 5Y
17.4
Industry
13.5
More Details
26.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
26.2
vs History
vs Industry
Median 3Y
26.2
Median 5Y
25.2
Industry
17.5
More Details
1.1
EV/IC
EV/IC
Enterprise Value to IC
1.1
vs History
vs Industry
Median 3Y
1.1
Median 5Y
1.1
Industry
1.8
More Details

Multiples Across Competitors

HLA Competitors Multiples
Healthia Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Healthia Ltd
ASX:HLA
251.6m AUD 1 46 13.2 13.2
US
Cigna Corp
NYSE:CI
87.7B USD 0.3 17.4 8.5 11
US
Cigna Group
XMUN:CGN
76.8B EUR 0.3 17.2 8.5 10.9
US
CVS Health Corp
NYSE:CVS
80.4B USD 0.2 15.2 12.7 12.7
DE
Fresenius Medical Care AG
XMUN:FME
31.4B EUR 1.6 50.9 13.4 29.7
DE
Fresenius SE & Co KGaA
XETRA:FRE
24.8B EUR 1.1 52.7 10.7 17.9
US
Laboratory Corporation of America Holdings
NYSE:LH
21B USD 1.6 28.8 14.6 23
US
Quest Diagnostics Inc
NYSE:DGX
20B USD 2 22.4 13 17.6
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
15.7B EUR 0.8 25.5 8.1 17.9
US
Hims & Hers Health Inc
NYSE:HIMS
13.7B USD 7.7 83.2 96.9 115.6
US
DaVita Inc
NYSE:DVA
11.3B USD 0.9 13.1 7.6 10.4

See Also

Summary
HLA intrinsic value, competitors valuation, and company profile.
DCF Valuation
HLA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HLA stock valuation using valuation multiples.
Wall Street Estimates
HLA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HLA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 256,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.